The overall risk of any infection in the first year after starting treatment is similar in people given different types…
Articles by Marisa Horak, MS
Bristol Myers Squibb‘s experimental cell therapy arlocabtagene autoleucel (arlo-cel) may help control myeloma…
A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward,…
September is Gynecologic Cancer Awareness Month, and advocacy groups are running campaigns to raise awareness about gynecological cancers,…
Since the late 1940s, when the first chemotherapies were introduced, advances in treatment for blood cancers have resulted in…
A novel mRNA vaccine effectively triggered an antitumor immune response in a mouse model of pancreatic cancer, even completely…
September is Blood Cancer Awareness Month, and advocates around the world are joining together to shine a light on…
Ionis Pharmaceuticals’ experimental injection therapy sapablursen may ease symptoms of polycythemia vera (PV) and reduce the need for…
The U.S. Food and Drug Administration (FDA) has approved an oral drug for adults with pancreatic adenocarcinoma, the most common…
Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations,…